IP Library Patent Application 14324673
Patent Application
App. No. 14/324,673

L-ARABINOSE PLUS CHROMIUM FOR CONTROLLING THE METABOLIZATION OF SUCROSE

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
14/324,673
Filed
Jul 7, 2014
Art Unit
1791
USPC
426/2
Abstract

The invention is directed to a composition comprising chromium and L-Arabinose. The invention is also directed to a method for decreasing the metabolization of sucrose in a host in need thereof by administering a composition comprising chromium and L-Arabinose to a host and a method for inhibiting the glycemic response to a meal containing sucrose in a host in need thereof by administering a composition comprising chromium and L-Arabinose to a host.

Claims (12)

1 . A composition comprising L-Arabinose and chromium.

2 . The composition according to claim 1 , wherein the L-Arabinose is in an amount of about 1000 mg.

3 . The composition according to claim 1 , wherein the chromium is in an amount of about 100 mg.

4 . The composition according to claim 1 , wherein the chromium is selection from the group consisting of chromium picolinate, chromium chloride, chromium niacin amino acid chelate and chromium nicotinate.

5 . A method for decreasing metabolization of sucrose in a host in need thereof comprising administering an effective amount of a composition comprising L-Arabinose and chromium to said host.

6 . The method according to claim 5 , wherein the L-Arabinose is in an amount of about 1000 mg.

7 . The method according to claim 5 , wherein the chromium is in an amount of about 100 mg.

8 . The method according to claim 5 , wherein the administration occurs before a meal.

9 . A method for inhibiting glycemic response to a meal containing sucrose in a host in need thereof comprising administering an effective amount of a composition comprising L-Arabinose and chromium to said host.

10 . The method according to claim 9 , wherein the L-Arabinose is in an amount of about 1000 mg.

11 . The method according to claim 9 , wherein the chromium is in an amount of about 100 mg.

12 . The method according to claim 9 , wherein the administration occurs before a meal.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →
SECURITY AGREEMENT Recorded Jul 3, 2017
From: AVOCA, INC.; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES, INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 043084/0753 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2017
From: SKOP, MITCH
To: PHARMACHEM LABORATORIES, INC
Reel/Frame 041949/0808 →